Market Position Cerbo operates in a HIPAA-compliant EHR space serving thousands of practitioners in functional and integrative medicine, direct primary care, and cash-based care models, indicating strong demand among private-practice segments and potential upsell to practices expanding into more compliant, integrated solutions.

Competitive Signals Competitor activity from Tabflows suggests a crowded market with interest in all-in-one EHR versus best-of-breed integrations; this indicates a sales opportunity to differentiate Cerbo with seamless connectivity options, HL7 interoperability, and focused value for integrative medicine workflows.

Executive Growth Recent leadership change with a new CEO signals strategic pivots and growth initiatives; this is a favorable touchpoint for enterprise pilots, strategic partnerships, and executive-level conversations around product roadmap alignment and scaling customer success.

Strategic Partnerships Past and ongoing partnerships to connect Lab results (e.g., DUTCH test) into EHRs via HL7 highlight Cerbo’s strength in interoperability; opportunity to target labs, diagnostic providers, and specialty testing firms for expanded integration and referral networks.

Financial Opportunity With a reported revenue range of 50M to 100M and a sizable customer base in private-practice segments, there is room to target mid-market practices with bundled pricing, expanded modules (inventory, secure messaging, billing), and premium support to drive higher ARPU and renewal rates.